Full Text (PDF)
Original Article

Impact of Myoinositol in Polycystic Ovarian Syndrome

Roya Rozati, ,

Author Information

Licence:




Indian Journal of Diabetes and Endocrinology 3(1):p 9-13, January-June 2021. | DOI:

How Cite This Article:

Wajeeda Tabasum, Roya Rozati, Ayapati Gautam Mehdi, et al./Impact of Myoinositol in Polycystic Ovarian Syndrome/Indian Journal of Diabetes and Endocrinology, 2021;3(1):9–13.
 


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

Polycystic ovary syndrome (PCOS) is one of the most common causes of infertility and metabolic problems among women of reproductive age. Myo inositol (MI) is administered in women with polycystic ovary syndrome (PCOS) over the last few years. It plays an important role in many metabolic pathways if the function is impact which affects the human health. Many hormonal and reproductive disorders associated with this disorder seem relieved by the supplement. The main symptom seems to be an increased androgen concentration, which in turn may contribute to different metabolic disorders which is improved in women with PCOS by supplementation of MI. Administration of MI is a safe and effective option to prevent and correct metabolic disorders in teenagers affected by PCOS. Thus, the aim of this review is to present the effectiveness of MI in the treatment for PCOS symptoms.


References

No records found.


About this article


Cite this article

Wajeeda Tabasum, Roya Rozati, Ayapati Gautam Mehdi, et al./Impact of Myoinositol in Polycystic Ovarian Syndrome/Indian Journal of Diabetes and Endocrinology, 2021;3(1):9–13.
 


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Tuesday 07 July 2026, 06:10:34 (IST)


593

Accesses

0
125
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share